Monomethyltransferase SETD8 regulates breast cancer metabolism via stabilizing hypoxia-inducible factor 1α

Run Huang1, Yang Yu2, Xiangyun Zong1

  • 1Department of Breast Surgery, Shanghai Jiao Tong University Affiliated Shanghai Sixth People's Hospital, 600 Yishan Road, Shanghai 200233, China.

Cancer Letters
|January 17, 2017
PubMed

Insights

The study reveals SETD8 (SET Domain Containing 8) regulates anabolic metabolism in breast cancer by stabilizing hypoxia-inducible factor 1α (HIF1α). This highlights SETD8

Area of Science:

  • Epigenetics and Cancer Metabolism
  • Molecular Biology
  • Biochemistry

Background:

  • SETD8 (SET Domain Containing 8) is a histone methyltransferase regulating cell cycle and DNA repair.
  • Previous research linked SETD8 to epithelial-mesenchymal transition (EMT) and breast cancer metastasis.
  • The role of SETD8 in cancer metabolism reprogramming remained unexplored.

Purpose of the Study:

  • To investigate the role of SETD8 in metabolic reprogramming in breast cancer.
  • To elucidate the molecular mechanisms by which SETD8 influences cancer metabolism.
  • To explore the clinical relevance of SETD8 in breast cancer patients.

Main Methods:

  • Cell-based assays to assess metabolic changes.
  • Western blotting and qRT-PCR to analyze protein and gene expression.
  • Analysis of clinical breast cancer patient tissues.

Main Results:

  • SETD8 acts as a positive regulator of anabolic metabolism in breast cancer cells.
  • SETD8 reprograms metabolism via a hypoxia-inducible factor 1α (HIF1α)-dependent pathway.
  • SETD8 stabilizes HIF1α protein levels through post-transcriptional regulation and is a HIF1α target gene.
  • A positive correlation between SETD8, HIF1α, and HIF1α target genes was observed in clinical samples.

Conclusions:

  • SETD8 is identified as a novel regulator of metabolic reprogramming in breast cancer.
  • The SETD8-HIF1α axis plays a crucial role in maintaining breast cancer malignancy.
  • These findings offer new insights into the functions of SETD8 in cancer progression.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.3K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.0K